CHARACTERIZATION OF MUSCARINIC ACETYLCHOLINE-RECEPTORS IN HUMAN LABIAL SALIVARY-GLANDS

被引:27
作者
MEI, L
ROESKE, WR
IZUTSU, KT
YAMAMURA, HI
机构
[1] UNIV ARIZONA,ARIZONA HLTH SCI CTR,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
[2] UNIV ARIZONA,ARIZONA HLTH SCI CTR,DEPT BIOCHEM,TUCSON,AZ 85724
[3] UNIV ARIZONA,ARIZONA HLTH SCI CTR,DEPT PSYCHIAT,TUCSON,AZ 85724
[4] UNIV WASHINGTON,DEPT ORAL BIOL,SEATTLE,WA 98195
关键词
Labial salivary gland (human); Muscarinic receptor antagonists; Muscarinic receptor subtypes;
D O I
10.1016/0014-2999(90)90032-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Muscarinic acetylcholine receptors were studied in human labial salivary glands with (-)-[3H]MQNB. The radioligand bound with a Kd value of 150 pM. The density of muscarinic receptors was 220 fmol/mg protein. Most muscarinic antagonists bound to a homogenous population of muscarinic receptors in this tissue. However, the inhibition curves of pirenzepine had a Hill slope of 0.57 and could be analyzed by a two site model. These results suggest that the muscarinic receptors in human labial salivary glands are a mixture of M1 and M3 types. © 1990.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 10 条
[1]   HETEROGENEITY OF THE M1 MUSCARINIC RECEPTOR SUBTYPE BETWEEN PERIPHERAL LUNG AND CEREBRAL-CORTEX DEMONSTRATED BY THE SELECTIVE ANTAGONIST AF-DX 116 [J].
BLOOM, JW ;
HALONEN, M ;
SEAVER, NA ;
YAMAMURA, HI .
LIFE SCIENCES, 1987, 41 (04) :491-496
[2]   CLONING AND EXPRESSION OF THE HUMAN AND RAT M5 MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
YOUNG, AC ;
BRANN, MR ;
BUCKLEY, NJ .
NEURON, 1988, 1 (05) :403-410
[3]  
CECCARELLI P, 1986, BASIC APPL HISTOCHEM, V30, P447
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   PIRENZEPINE DISTINGUISHES BETWEEN DIFFERENT SUBCLASSES OF MUSCARINIC RECEPTORS [J].
HAMMER, R ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
NATURE, 1980, 283 (5742) :90-92
[6]   ELECTRON-MICROPROBE ANALYSIS OF HUMAN LABIAL GLAND SECRETORY GRANULES IN CYSTIC-FIBROSIS [J].
IZUTSU, K ;
JOHNSON, D ;
SCHUBERT, M ;
WANG, E ;
RAMSEY, B ;
TAMARIN, A ;
TRUELOVE, E ;
ENSIGN, W ;
YOUNG, M .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (06) :1951-1956
[7]  
IZUTSU KT, 1989, LAB INVEST, V60, P158
[8]  
KORC M, 1987, J PHARMACOL EXP THER, V240, P118
[9]  
LADINSKY H, 1988, TRENDS PHARM SCI S, V9, P44
[10]  
MICHELETTI R, 1987, J PHARMACOL EXP THER, V241, P628